MetLife Forecast, price target & analysts
MetLife Target price 2025 - Analyst rating & recommendation
MetLife Classifications & Recommendation:
MetLife Price Target
| Target Price | $96.93 |
| Price | $82.74 |
| Potential |
17.15%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target MetLife 2026 .
The average MetLife target price is $96.93.
This is
17.15%
register free of charge
$110.00
32.95%
register free of charge
$81.00
2.10%
register free of charge
|
|
| A rating was issued by 20 analysts: 13 Analysts recommend MetLife to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MetLife stock has an average upside potential 2026 of
17.15%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 70.99 | 75.86 |
| 6.10% | 6.87% | |
| Net Margin | 5.77% | 8.30% |
| 209.31% | 43.92% |
9 Analysts have issued a sales forecast MetLife 2025 . The average MetLife sales estimate is
This results in the following potential growth metrics:
10 MetLife Analysts have issued a net profit forecast 2025. The average MetLife net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 5.94 | 9.13 |
| 228.18% | 53.70% | |
| P/E | 9.06 | |
| EV/Sales | 0.74 |
10 Analysts have issued a MetLife forecast for earnings per share. The average MetLife <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the MetLife stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current MetLife Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo | Overweight ➜ Overweight | Unchanged | Feb 19 2025 |
| Keefe, Bruyette & Woods | Outperform ➜ Outperform | Unchanged | Feb 12 2025 |
| Barclays | Overweight ➜ Overweight | Unchanged | Feb 07 2025 |
| BMO Capital | ➜ Market Perform | Initiated | Jan 23 2025 |
| Wells Fargo | Overweight ➜ Overweight | Unchanged | Jan 14 2025 |
| JP Morgan | Overweight ➜ Overweight | Unchanged | Jan 07 2025 |
| Barclays | Overweight ➜ Overweight | Unchanged | Jan 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wells Fargo: Overweight ➜ Overweight
|
Feb 19 2025 |
|
Unchanged
Keefe, Bruyette & Woods: Outperform ➜ Outperform
|
Feb 12 2025 |
|
Unchanged
Barclays: Overweight ➜ Overweight
|
Feb 07 2025 |
|
Initiated
BMO Capital: ➜ Market Perform
|
Jan 23 2025 |
|
Unchanged
Wells Fargo: Overweight ➜ Overweight
|
Jan 14 2025 |
|
Unchanged
JP Morgan: Overweight ➜ Overweight
|
Jan 07 2025 |
|
Unchanged
Barclays: Overweight ➜ Overweight
|
Jan 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
